7.78

0.91% 0.06

Chromadex Corp (CDXC)

Overview News Price History Option Chain Financials Discussions Forecast Stock Split

Chromadex Corp stock is traded at $7.78, with a volume of 81,073. It is up +0.91% in the last 24 hours and up +32.71% over the past month. ChromaDex Corp is a bioscience company dedicated to healthy aging. It is engaged in research on nicotinamide adenine dinucleotide (NAD+), levels of which decline with age. The company is the innovator behind NAD+ precursor nicotinamide riboside (NR), commercialized as the flagship ingredient Niagen. The company has three reportable segments namely Consumer Products, Ingredients segment, and Analytical Reference Standards and Services. The majority of the revenue is earned from the Consumer Products segment.

Previous Close:

$7.72

Open:

$7.76

24h Volume:

81,073

Relative Volume:

0.11

Market Cap:

$586.18M

Revenue:

$83.57M

Net Income/Loss:

$-4.94M

P/E Ratio:

-111.14

EPS:

-0.07

Net Cash Flow:

$6.97M

1W Performance:

+1.17%

1M Performance:

+32.71%

6M Performance:

+119.44%

1Y Performance:

+280.00%

1-Day Range:

$7.67

$7.84

1-Week Range:

$7.3248

$8.19

52-Week Range:

$2.0201

$9.18

Chromadex Corp Stock (CDXC) Company Profile

Name

Chromadex Corp

Sector

Consumer Defensive (245)

Industry

Packaged Foods (72)

Phone

310-388-6706

Address

10900 WILSHIRE BLVD, LOS ANGELES

Employee

106

Twitter

@Chromadex

Next Earnings Date

2025-03-04

Latest SEC Filings

CDXC's Discussions on Twitter

Compare CDXC with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
CDXC Chromadex Corp	7.701	586.18M	83.57M	-4.94M	6.97M	-0.07
KHC Kraft Heinz Co	30.39	36.98B	25.85B	2.74B	3.02B	2.26
GIS General Mills Inc	59.63	33.00B	19.90B	2.60B	2.80B	4.60
K Kellanova	82.26	28.11B	12.75B	1.34B	1.13B	3.87
MKC Mccormick Co Inc	80.42	21.49B	6.68B	792.60M	774.40M	2.94
HRL Hormel Foods Corp	29.53	16.31B	11.92B	805.04M	1.01B	1.46

Chromadex Corp Stock (CDXC) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-16-22	Downgrade	Oppenheimer	Outperform → Perform
Aug-11-22	Downgrade	B. Riley Securities	Buy → Neutral
Mar-08-22	Initiated	ROTH Capital	Buy
Oct-16-19	Initiated	Oppenheimer	Outperform
Feb-14-19	Initiated	B. Riley FBR	Buy
Nov-27-17	Resumed	H.C. Wainwright	Buy
Sep-25-17	Initiated	Ladenburg Thalmann	Buy
Jan-03-17	Initiated	Rodman & Renshaw	Buy

View All

Chromadex Corp Stock (CDXC) Latest News

Mar 13, 2025

Q1 Earnings Forecast for ChromaDex Issued By HC Wainwright - Defense World

Mar 13, 2025

ChromaDex Corp. Announces Name Change to Niagen Bioscience, Inc. and New Ticker Symbol "NAGE" Effective March 19, 2025 - BioSpace

Mar 13, 2025

ChromaDex to rebrand as Niagen Bioscience and change ticker - Investing.com India

Mar 13, 2025

Major Rebrand: ChromaDex Evolves to Niagen Bioscience, Sharpens Focus on Aging Science - StockTitan

Mar 13, 2025

Mar 11, 2025

ChromaDex to Present at the 37th Annual Roth Conference - Bluefield Daily Telegraph

Mar 11, 2025

Healthy Aging Leader ChromaDex Takes Center Stage at ROTH Conference Longevity Panel - StockTitan

Mar 11, 2025

ChromaDex (NASDAQ:CDXC) Given New $11.00 Price Target at HC Wainwright - Defense World

Mar 11, 2025

Mar 10, 2025

ChromaDex stock price target raised to $11 by H.C. Wainwright - Investing.com Australia

Mar 10, 2025

Chromadex corp. SVP buys $2,145 worth of common stock - Investing.com

Mar 10, 2025

ChromaDex Co. (NASDAQ:CDXC) Shares Bought by Rhumbline Advisers - Defense World

Mar 10, 2025

Mar 08, 2025

Truist Financial Corp Makes New $54,000 Investment in ChromaDex Co. (NASDAQ:CDXC) - Defense World

Mar 08, 2025

StockNews.com Downgrades ChromaDex (NASDAQ:CDXC) to Buy - Defense World

Mar 08, 2025

Mar 07, 2025

ChromaDex (NASDAQ:CDXC) Stock Price Expected to Rise, LADENBURG THALM/SH SH Analyst Says - Defense World

Mar 07, 2025

FY2025 EPS Estimates for ChromaDex Boosted by Roth Capital - Defense World

Mar 07, 2025

Mar 06, 2025

Earnings call transcript: Chromadex’s Q4 2024 earnings beat forecasts, stock rises - Investing.com Australia

Mar 06, 2025

ChromaDex Corporation Just Beat Earnings Expectations: Here's What Analysts Think Will Happen Next - Yahoo Finance

Mar 06, 2025

Mar 05, 2025

ChromaDex stock soars to 52-week high, touches $7.98 By Investing.com - Investing.com Canada

Mar 05, 2025

ChromaDex Reports Record Revenues Amid Challenges - TipRanks

Mar 05, 2025

Tru Niagen’s ChromaDex reports profit, nearly $100 million in yearly sales - SupplySide Supplement Journal

Mar 05, 2025

ChromaDex stock soars to 52-week high, touches $7.98 - Investing.com India

Mar 05, 2025

ChromaDex Corporation (NASDAQ:CDXC) Q4 2024 Earnings Call Transcript - Insider Monkey

Mar 05, 2025

ChromaDex: Q4 Earnings Snapshot - Midland Daily News

Mar 05, 2025